References

Sui H, Zhu L, Deng W, Li Q. Epithelial-mesenchymal transition and drug resistance: role, molecular mechanisms, and therapeutic strategies. Oncology research and treatment. 2014;37(10):584-9.

Marconi GD, Fonticoli L, Rajan TS, Pierdomenico SD, Trubiani O, Pizzicannella J, et al. Epithelial-mesenchymal transition (EMT): the type-2 EMT in wound healing, tissue regeneration and organ fibrosis. Cells. 2021;10(7):1587.

Kerosuo L, Bronner-Fraser M, editors. What is bad in cancer is good in the embryo: importance of EMT in neural crest development. Seminars in Cell & developmental biology; 2012: Elsevier.

Elsum IA, Martin C, Humbert PO. Scribble regulates an EMT polarity pathway through modulation of MAPK-ERK signaling to mediate junction formation. Journal of cell science. 2013;126(17):3990-9.

Bazellières E, Aksenova V, Barthélémy-Requin M, Massey-Harroche D, Le Bivic A, editors. Role of the Crumbs proteins in ciliogenesis, cell migration and actin organization. Seminars in Cell & developmental biology; 2018: Elsevier.

Lu Z, Yuan S, Ruan L, Tu Z, Liu H. Partitioning defective 6 homolog alpha (PARD6A) promotes epithelial–mesenchymal transition via integrin β1-ILK-SNAIL1 pathway in ovarian cancer. Cell Death & Disease. 2022;13(4):304.

Ferreira AR, Felgueiras J, Fardilha M. Signaling pathways in anchoring junctions of epithelial cells: cell-to-cell and cell-to-extracellular matrix interactions. Journal of Receptors and Signal Transduction. 2015;35(1):67-75.

Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. Journal of hematology & oncology. 2022;15(1):129.

Goossens S, Vandamme N, Van Vlierberghe P, Berx G. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2017;1868(2):584-91.

Tan M, Chuang VY, Tan TZ, Thiery JP, Huang RY-J. Transcriptional regulatory loops among SNAI1, TWIST1, ZEB1, and ZEB2 defines the epithelial-mesenchymal transition (EMT) spectrum in epithelial ovarian cancer (EOC). Cancer Research. 2015;75(15_Supplement):1430-.

Katoh M, Katoh M. Cross-talk of WNT and FGF signaling pathways at GSK3ß to regulate ß-catenin and SNAIL signaling cascades. Cancer biology & therapy. 2006;5(9):1059-64.

Yan L, Coletta LD, Powell KL, Shen J, Thames H, Aldaz CM, et al. Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors. PloS one. 2011;6(1):e16515.

Aashaq S, Batool A, Mir SA, Beigh MA, Andrabi KI, Shah ZA. TGF‐β Signaling: A Recap of SMAD‐independent and SMAD‐dependent Pathways. Journal of cellular physiology. 2022;237(1):59-85.

Xu J, Lamouille S, Derynck R. TGF-β-induced epithelial to mesenchymal transition. Cell research. 2009;19(2):156-72.

Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature. 2003;425(6958):577-84.

Zhang YE. Non-Smad signaling pathways of the TGF-β family. Cold Spring Harbor perspectives in biology. 2017;9(2):a022129.

Marcucci F, Stassi G, De Maria R. Epithelial–mesenchymal transition: a new target in anti-cancer drug discovery. Nature reviews Drug discovery. 2016;15(5):311-25.

Guo M, Niu Y, Xie M, Liu X, Li X. Notch signaling, hypoxia, and cancer. Frontiers in Oncology. 2023;13:1078768.

Wang Z, Li Y, Kong D, H Sarkar F. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Current drug targets. 2010;11(6):745-51.

Mutha RE, Tatiya AU, Surana SJ. Flavonoids as natural phenolic compounds and their role in therapeutics: An overview. Future journal of pharmaceutical sciences. 2021;7:1-13.

Veeramuthu D, Raja WRT, Al-Dhabi NA, Savarimuthu I. Flavonoids: anti-cancer properties. Flavonoids-From biosynthesis to human health. 2017;287.

Weng C-J, Yen G-C. Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer and Metastasis Reviews. 2012;31:323-51.

Lim H, Kim HP. Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids. Planta medica. 2007;73(12):1267-74.

Kim MH. Flavonoids inhibit VEGF/bFGF‐induced angiogenesis in vitro by inhibiting the matrix‐degrading proteases. Journal of cellular biochemistry. 2003;89(3):529-38.

Ma Y, Yuan H, Jin R, Bao X, Wang H, Su X, et al. Flavonoid-rich Scabiosa comosa inflorescence extract attenuates CCl4-induced hepatic fibrosis by modulating TGF-β-induced Smad3 phosphorylation. Biomedicine & Pharmacotherapy. 2018;106:426-33.

Liskova A, Koklesova L, Samec M, Smejkal K, Samuel SM, Varghese E, et al. Flavonoids in cancer metastasis. Cancers. 2020;12(6):1498.

Ang HL, Mohan CD, Shanmugam MK, Leong HC, Makvandi P, Rangappa KS, et al. Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds. Medicinal research reviews. 2023;43(4):1141-200.

Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer and metastasis reviews. 2009;28:15-33.

Jung H-Y, Fattet L, Tsai JH, Kajimoto T, Chang Q, Newton AC, et al. Apical–basal polarity inhibits epithelial–mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation. Nature cell biology. 2019;21(3):359-71.

Smith BN, Bhowmick NA. Role of EMT in metastasis and therapy resistance. Journal of clinical medicine. 2016;5(2):17.

Mosa MH, Michels BE, Menche C, Nicolas AM, Darvishi T, Greten FR, et al. A Wnt-induced phenotypic switch in cancer-associated fibroblasts inhibits EMT in colorectal cancer. Cancer research. 2020;80(24):5569-82.

Cao Z, Livas T, Kyprianou N. Anoikis and EMT: lethal" liaisons" during cancer progression. Critical Reviews™ in Oncogenesis. 2016;21(3-4).

Kumar S, Park SH, Cieply B, Schupp J, Killiam E, Zhang F, et al. A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Molecular and cellular biology. 2011;31(19):4036-51.

Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Molecular cancer. 2016;15:1-14.

Santarosa M, Maestro R. The autophagic route of E-cadherin and cell adhesion molecules in cancer progression. Cancers. 2021;13(24):6328.

Hämäläinen L, Soini Y, Pasonen‐Seppänen S, Siponen M. Alterations in the expression of EMT‐related proteins claudin‐1, claudin‐4 and claudin‐7, E‐cadherin, TWIST1 and ZEB1 in oral lichen planus. Journal of Oral Pathology & Medicine. 2019;48(8):735-44.

De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, Redeuilh G, et al. Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front. Histochemistry and cell biology. 2008;130:481-94.

Kaufhold S, Bonavida B. Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. Journal of Experimental & Clinical Cancer Research. 2014;33:1-19.

Guttilla Reed IK. Mechanism and regulation of epithelial–mesenchymal transition in cancer. Cell Health and Cytoskeleton. 2015:155-66.

Castillo-Lluva S, Hontecillas-Prieto L, Blanco-Gómez A, del Mar Sáez-Freire M, García-Cenador B, García-Criado J, et al. A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development. Oncogene. 2015;34(36):4777-90.

Xue W, Yang L, Chen C, Ashrafizadeh M, Tian Y, Sun R. Wnt/β-catenin-driven EMT regulation in human cancers. Cellular and Molecular Life Sciences. 2024;81(1):79.

Fuxe J, Vincent T, Garcia de Herreros A. Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell cycle. 2010;9(12):2363-74.

Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R. Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mechanisms of development. 1996;59(1):3-10.

Bisoyi P. Malignant tumors–as cancer. Understanding Cancer: Elsevier; 2022. p. 21-36.

Du B, Shim JS. Targeting epithelial–mesenchymal transition (EMT) to overcome drug resistance in cancer. Molecules. 2016;21(7):965.

Dongre A, Rashidian M, Reinhardt F, Bagnato A, Keckesova Z, Ploegh HL, et al. Epithelial-to-mesenchymal transition contributes to immunosuppression in breast carcinomas. Cancer research. 2017;77(15):3982-9.

Trono P, Sistigu A, Palermo B, Ciliberto G, Nisticò P. Mesenchymal traits at the convergence of tumor-intrinsic and-extrinsic mechanisms of resistance to immune checkpoint blockers. Emerging Topics in Life Sciences. 2017;1(5):471-86.

Kvokačková B, Remšík J, Jolly MK, Souček K. Phenotypic heterogeneity of triple-negative breast cancer mediated by epithelial–mesenchymal plasticity. Cancers. 2021;13(9):2188.

Gurzu S, Turdean S, Kovecsi A, Contac AO, Jung I. Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update. World Journal of Clinical Cases: WJCC. 2015;3(5):393.

Agoro R, Mura C. Inflammation-induced up-regulation of hepcidin and down-regulation of ferroportin transcription are dependent on macrophage polarization. Blood Cells, Molecules, and Diseases. 2016;61:16-25.

Georgakopoulos-Soares I, Chartoumpekis DV, Kyriazopoulou V, Zaravinos A. EMT factors and metabolic pathways in cancer. Frontiers in oncology. 2020;10:499.

Vallenius T. Actin stress fibre subtypes in mesenchymal-migrating cells. Open biology. 2013;3(6):130001.

Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nature reviews Molecular cell biology. 2009;10(7):445-57.

Paňková K, Rösel D, Novotný M, Brábek J. The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells. Cellular and molecular life sciences. 2010;67:63-71.

Leong SP, Naxerova K, Keller L, Pantel K, Witte M. Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels. Clinical & experimental metastasis. 2022;39(1):159-79.

Zhou Y, Xia L, Wang H, Oyang L, Su M, Liu Q, et al. Cancer stem cells in progression of colorectal cancer. Oncotarget. 2017;9(70):33403.

Niland S, Riscanevo AX, Eble JA. Matrix metalloproteinases shape the tumor microenvironment in cancer progression. International journal of molecular sciences. 2021;23(1):146.

Chatterjee S. Interplay Between Epithelial-Mesenchymal Transition and Cancer Stem Cells: Unveiling Potential Therapeutic Avenues. 2024.

Mekkawy AH, Pourgholami MH, Morris DL. Involvement of urokinase‐type plasminogen activator system in cancer: An overview. Medicinal research reviews. 2014;34(5):918-56.

Santibanez JF. Urokinase type plasminogen activator and the molecular mechanisms of its regulation in cancer. Protein and peptide letters. 2017;24(10):936-46.

Rodrigues M, Kosaric N, Bonham CA, Gurtner GC. Wound healing: a cellular perspective. Physiological reviews. 2018.

Lee J, Yon DK, Choi YS, Lee J, Yeo JH, Kim SS, et al. Roles of SMAD and SMAD-Associated Signaling Pathways in Nerve Regeneration Following Peripheral Nerve Injury: A Narrative Literature Review. Current Issues in Molecular Biology. 2024;46(7):7769-81.

Runa F, Ortiz-Soto G, de Barros NR, Kelber JA. Targeting SMAD-dependent signaling: considerations in epithelial and mesenchymal solid tumors. Pharmaceuticals. 2024;17(3):326.

Tuerhong N, Yang Y, Wang C, Huang P, Li Q. Interactions between platelets and the cancer immune microenvironment. Critical Reviews in Oncology/Hematology. 2024:104380.

Krumova K, Cosa G. Overview of reactive oxygen species. 2016.

Preiser JC. Oxidative stress. Journal of Parenteral and Enteral Nutrition. 2012;36(2):147-54.

Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis. 2007;12:913-22.

Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug resistance updates. 2004;7(2):97-110.

Lebelo MT, Joubert AM, Visagie MH. Warburg effect and its role in tumourigenesis. Archives of pharmacal research. 2019;42(10):833-47.

Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive Oxygen Species (ROS)––Induced genetic and epigenetic alterations in human carcinogenesis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2011;711(1-2):167-73.

Guo Y-J, Pan W-W, Liu S-B, Shen Z-F, Xu Y, Hu L-L. ERK/MAPK signalling pathway and tumorigenesis. Experimental and therapeutic medicine. 2020;19(3):1997-2007.

Asl ER, Amini M, Najafi S, Mansoori B, Mokhtarzadeh A, Mohammadi A, et al. Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression. Life sciences. 2021;278:119499.

Mdkhana B, Goel S, Saleh MA, Siddiqui R, Khan NA, Elmoselhi AB. Role of oxidative stress in angiogenesis and the therapeutic potential of antioxidants in breast cancer. European Review for Medical and Pharmacological Sciences. 2022;26(13):4677-92.

Wu X, Kassie F, Mersch-Sundermann V. Induction of apoptosis in tumor cells by naturally occurring sulfur-containing compounds. Mutation Research/Reviews in Mutation Research. 2005;589(2):81-102.

Jurkowska H, Wróbel M, Kaczor-Kamińska M, Jasek-Gajda E. A possible mechanism of inhibition of U87MG and SH-SY5Y cancer cell proliferation by diallyl trisulfide and other aspects of its activity. Amino Acids. 2017;49:1855-66.

Craddock J, Neale E, Peoples G, Probst Y. Plant‐based eating patterns and endurance performance: A focus on inflammation, oxidative stress and immune responses. Nutrition Bulletin. 2020;45(2):123-32.

Sahakyan N, Nasim MJ, Jacob C. Redoxification (of the organism) through Diet and supplementation with a Focus on Natural Polymeric Redox Modulators. Current Pharmacology Reports. 2024;10(2):85-95.

Bianchini F, Vainio H. Allium vegetables and organosulfur compounds: do they help prevent cancer? Environmental health perspectives. 2001;109(9):893-902.

Miękus N, Marszałek K, Podlacha M, Iqbal A, Puchalski C, Świergiel AH. Health benefits of plant-derived sulfur compounds, glucosinolates, and organosulfur compounds. Molecules. 2020;25(17):3804.

Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, et al. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. The Journal of Immunology. 2007;179(10):7121-7.

Knickle A, Rasmussen A, Hoskin DW. Myricetin induces apoptosis mediated by oxidative stress in 4T1 and E0771 mammary cancer cells. Molecular & Cellular Toxicology. 2020;16:283-9.

Eanes LA, Eldeeb M, Storholt D, Patel YM. Naringenin impairs mitochondrial function via ROS to induce apoptosis in tamoxifen resistant MCF-7 breast cancer cells. PloS one. 2025;20(4):e0320020.

Rahmani AH, Alsahli MA, Almatroudi A, Almogbel MA, Khan AA, Anwar S, et al. The potential role of apigenin in cancer prevention and treatment. Molecules. 2022;27(18):6051.

Lin C-H, Chang C-Y, Lee K-R, Lin H-J, Chen T-H, Wan L. Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway. BMC cancer. 2015;15:1-12.

Smith M, Wilkinson S. ER homeostasis and autophagy. Essays in biochemistry. 2017;61(6):625-35.

Wang M, Kaufman RJ. The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nature Reviews Cancer. 2014;14(9):581-97.

Corazzari M, Gagliardi M, Fimia GM, Piacentini M. Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Frontiers in oncology. 2017;7:78.

Clarke R, Cook KL, Hu R, Facey CO, Tavassoly I, Schwartz JL, et al. Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate. Cancer research. 2012;72(6):1321-31.

Hu H, Tian M, Ding C, Yu S. The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Frontiers in immunology. 2019;9:3083.

Yang Y, Liu L, Naik I, Braunstein Z, Zhong J, Ren B. Transcription factor C/EBP homologous protein in health and diseases. Frontiers in immunology. 2017;8:1612.

Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nature cell biology. 2011;13(3):184-90.

Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2013;1833(12):3460-70.

Reid DW, Tay AS, Sundaram JR, Lee IC, Chen Q, George SE, et al. Complementary roles of GADD34-and CReP-containing eukaryotic initiation factor 2α phosphatases during the unfolded protein response. Molecular and cellular biology. 2016;36(13):1868-80.

Shi J-M, Bai L-L, Zhang D-M, Yiu A, Yin Z-Q, Han W-L, et al. Saxifragifolin D induces the interplay between apoptosis and autophagy in breast cancer cells through ROS-dependent endoplasmic reticulum stress. Biochemical pharmacology. 2013;85(7):913-26.

Multhoff G, Molls M, Radons J. Chronic inflammation in cancer development. Frontiers in immunology. 2012;2:98.

Vishnoi K, Viswakarma N, Rana A, Rana B. Transcription factors in cancer development and therapy. Cancers. 2020;12(8):2296.

Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochemical pharmacology. 2002;64(5-6):883-8.

Escarcega R, Fuentes-Alexandro S, Garcia-Carrasco M, Gatica A, Zamora A. The transcription factor nuclear factor-kappa B and cancer. Clinical Oncology. 2007;19(2):154-61.

Gambhir S, Vyas D, Hollis M, Aekka A, Vyas A. Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies. World journal of gastroenterology: WJG. 2015;21(11):3174.

Kim JH, Gupta SC, Park B, Yadav VR, Aggarwal BB. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)‐κB and NF‐κB‐regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Molecular nutrition & food research. 2012;56(3):454-65.

Xu X, Zhu Y. Curcumin inhibits human non-small cell lung cancer xenografts by targeting STAT3 pathway. American journal of translational research. 2017;9(8):3633.

Chung SS, Dutta P, Chard N, Wu Y, Chen Q-H, Chen G, et al. A novel curcumin analog inhibits canonical and non-canonical functions of telomerase through STAT3 and NF-κB inactivation in colorectal cancer cells. Oncotarget. 2019;10(44):4516.

Yang J-Y, Zhong X, Yum H-W, Lee H-J, Kundu JK, Na H-K, et al. Curcumin inhibits STAT3 signaling in the colon of dextran sulfate sodium-treated mice. Journal of cancer prevention. 2013;18(2):186.

Yuan M, Zhang G, Bai W, Han X, Li C, Bian S. The role of bioactive compounds in natural products extracted from plants in cancer treatment and their mechanisms related to anti-cancer effects. Oxidative Medicine and Cellular Longevity. 2022;2022(1):1429869.

Gangemi R, Paleari L, Orengo AM, Cesario A, Chessa L, Ferrini S, et al. Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Current medicinal chemistry. 2009;16(14):1688-703.

De Angelis ML, Francescangeli F, Zeuner A. Breast cancer stem cells as drivers of tumor chemoresistance, dormancy and relapse: new challenges and therapeutic opportunities. Cancers. 2019;11(10):1569.

O'Brien CA, Kreso A, Jamieson CH. Cancer stem cells and self-renewal. Clinical cancer research. 2010;16(12):3113-20.

Sugihara E, Saya H. Complexity of cancer stem cells. International journal of cancer. 2013;132(6):1249-59.

Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. Journal of cellular physiology. 2019;234(6):8381-95.

Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nature reviews Clinical oncology. 2015;12(8):445-64.

Zhou W, Kallifatidis G, Baumann B, Rausch V, Mattern J, Gladkich J, et al. Dietary polyphenol quercetin targets pancreatic cancer stem cells. International journal of oncology. 2010;37(3):551-61.

Abdal Dayem A, Choi HY, Yang G-M, Kim K, Saha SK, Cho S-G. The anti-cancer effect of polyphenols against breast cancer and cancer stem cells: molecular mechanisms. Nutrients. 2016;8(9):581.

Fujiki H, Watanabe T, Sueoka E, Rawangkan A, Suganuma M. Cancer prevention with green tea and its principal constituent, EGCG: From early investigations to current focus on human cancer stem cells. Molecules and cells. 2018;41(2):73-82.

Chaudhuri R, Samanta A, Saha P, Ghosh S, Sinha D. The potential of epigallocatechin gallate in targeting cancer stem cells: A comprehensive review. Current Medicinal Chemistry. 2024;31(32):5255-80.

Herreros-Villanueva M, Er T-K, Bujanda L. Retinoic acid reduces stem cell–like features in pancreatic cancer cells. Pancreas. 2015;44(6):918-24.

Bonuccelli G, Sotgia F, Lisanti MP. Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways. Aging (Albany NY). 2018;10(8):1867.

Salajegheh A, Salajegheh A. Introduction to angiogenesis in normal physiology, disease and malignancy. Angiogenesis in health, disease and malignancy. 2016:1-9.

Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. Mechanisms of angiogenesis. 2005:209-31.

Favier J, Corvol P. Physiological angiogenesis. Therapie. 2001;56(5):455-63.

Singh RP, Agarwal R. Tumor angiogenesis: a potential target in cancer control by phytochemicals. Current cancer drug targets. 2003;3(3):205-17.

Rashidi B, Malekzadeh M, Goodarzi M, Masoudifar A, Mirzaei H. Green tea and its anti-angiogenesis effects. Biomedicine & Pharmacotherapy. 2017;89:949-56.

Liang D, Liu L, Zhao Y, Luo Z, He Y, Li Y, et al. Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer. Frontiers in Pharmacology. 2023;14:1186712.

Pralea I-E, Petrache A-M, Tigu AB, Gulei D, Moldovan R-C, Ilieș M, et al. Phytochemicals as regulators of tumor glycolysis and hypoxia signaling pathways: evidence from in vitro studies. Pharmaceuticals. 2022;15(7):808.

Salmaninejad A, Valilou SF, Soltani A, Ahmadi S, Abarghan YJ, Rosengren RJ, et al. Tumor-associated macrophages: role in cancer development and therapeutic implications. Cellular oncology. 2019;42:591-608.

Wang S-C, Hong J-H, Hsueh C, Chiang C-S. Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Laboratory investigation. 2012;92(1):151-62.

Zhou R, Xu L, Ye M, Liao M, Du H, Chen H. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways. Hormone and metabolic research. 2014;46(11):753-60.

Izuta H, Shimazawa M, Tsuruma K, Araki Y, Mishima S, Hara H. Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells. BMC complementary and alternative medicine. 2009;9:1-10.

Kunimasa K, Ikekita M, Sato M, Ohta T, Yamori Y, Ikeda M, et al. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis‐related endothelial cell functions and angiogenesis in vivo. Cancer science. 2010;101(11):2462-9.

Tornese R, Montefusco A, Placì R, Semeraro T, Durante M, De Caroli M, et al. Antiangiogenic potential of pomegranate extracts. Plants. 2024;13(23):3350.

Almatroodi SA, Almatroudi A, Alharbi HOA, Khan AA, Rahmani AH. Effects and mechanisms of luteolin, a plant-based flavonoid, in the prevention of cancers via modulation of inflammation and cell signaling molecules. Molecules. 2024;29(5):1093.

Zhang C, Wang N, Tan H-Y, Guo W, Li S, Feng Y. Targeting VEGF/VEGFRs pathway in the antiangiogenic treatment of human cancers by traditional Chinese medicine. Integrative cancer therapies. 2018;17(3):582-601.

Cao Y, Fu Z-D, Wang F, Liu H-Y, Han R. Antiangiogenic activity of resveratrol, a natural compound from medicinal plants. Journal of Asian natural products research. 2005;7(3):205-13.

Cui E-J, Hwang-Bo J, Park J-H, Baek N-I, Kim J, Hong SG, et al. 3-O-Acetyloleanolic acid exhibits antiangiogenic effects and induces apoptosis in human umbilical vein endothelial cells. Biotechnology letters. 2013;35:1807-15.

Chung H, Choi HS, Seo E-K, Kang D-H, Oh E-S. Baicalin and baicalein inhibit transforming growth factor-β1-mediated epithelial-mesenchymal transition in human breast epithelial cells. Biochemical and Biophysical Research Communications. 2015;458(3):707-13.

Zieniuk B, Uğur Ş. The Therapeutic Potential of Baicalin and Baicalein in Breast Cancer: A Systematic Review of Mechanisms and Efficacy. Current Issues in Molecular Biology. 2025;47(3):181.

Avila-Carrasco L, Majano P, Sánchez-Toméro JA, Selgas R, López-Cabrera M, Aguilera A, et al. Natural plants compounds as modulators of epithelial-to-mesenchymal transition. Frontiers in pharmacology. 2019;10:715.

Chen J, Chang H, Peng X, Gu Y, Yi L, Zhang Q, et al. 3, 6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway. Scientific reports. 2016;6(1):28858.

Kim HA, Lee J. Hispidulin modulates epithelial-mesenchymal transition in breast cancer cells. Oncology Letters. 2021;21(2):155.

Liskova A, Koklesova L, Samec M, Varghese E, Abotaleb M, Samuel SM, et al. Implications of flavonoids as potential modulators of cancer neovascularity. Journal of cancer research and clinical oncology. 2020;146:3079-96.

Sonowal H, Ramana KV. 2′-Hydroxyflavanone prevents LPS-induced inflammatory response and cytotoxicity in murine macrophages. Toxicology in Vitro. 2020;69:104966.

Şöhretoğlu D, Arroo R, Sari S, Huang S. Flavonoids as inducers of apoptosis and autophagy in breast cancer. Discovery and development of anti-breast cancer agents from natural products: Elsevier; 2021. p. 147-96.

Cherian J, Sehgal A, Singh SK, Vamanu E, Singh MP. 2′-Hydroxyflavanone: a bioactive compound that protects against cancers. Applied Sciences. 2022;12(19):9543.

Zhao X-C, Cao X-C, Liu F, Quan M-F, Ren K-Q, Cao J-G. Regulation of the FOXO3a/Bim signaling pathway by 5, 7-dihydroxy-8-nitrochrysin in MDA-MB-453 breast cancer cells. Oncology letters. 2013;5(3):929-34.

He Y, Shi Y, Yang Y, Huang H, Feng Y, Wang Y, et al. Chrysin induces autophagy through the inactivation of the ROS-mediated Akt/mTOR signaling pathway in endometrial cancer. International Journal of Molecular Medicine. 2021;48(3):172.

Hong TB, Rahumatullah A, Yogarajah T, Ahmad M, Yin KB. Potential effects of chrysin on MDA-MB-231 cells. International Journal of Molecular Sciences. 2010;11(3):1057-69.

Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway: evidence for direct inhibition of ERK1/2 and AKT kinases. Journal of Biological Chemistry. 2004;279(13):12755-62.

Balakrishnan S, Bhat F, Raja Singh P, Mukherjee S, Elumalai P, Das S, et al. Gold nanoparticle–conjugated quercetin inhibits epithelial–mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR‐2‐mediated pathway in breast cancer. Cell proliferation. 2016;49(6):678-97.

Arzi L, Mollaei H, Hoshyar R. Countering triple negative breast cancer via impeding Wnt/β-catenin signaling, a phytotherapeutic approach. Plants. 2022;11(17):2191.

Ma X, Yan W, Dai Z, Gao X, Ma Y, Xu Q, et al. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Drug Design, Development and Therapy. 2016:1419-41.

Paul A, Das P, Gogoi M, Islam MA, Das S, Zaman MK. Baicalein: multiple pharmacological activities, pharmacokinetics, and clinical trials. Revista Brasileira de Farmacognosia. 2024:1-15.

Hegde M, Archana P, Mumbrekar KD. Exploring baicalein: A natural flavonoid for enhancing cancer prevention and treatment. Heliyon. 2024;10(23).

Hosseinzadeh A, Poursoleiman F, Biregani AN, Esmailzadeh A. Flavonoids target different molecules of autophagic and metastatic pathways in cancer cells. Cancer Cell International. 2023;23(1):114.

Rocchetti MT, Bellanti F, Zadorozhna M, Fiocco D, Mangieri D. Multi-faceted role of luteolin in cancer metastasis: EMT, angiogenesis, ECM degradation and apoptosis. International Journal of Molecular Sciences. 2023;24(10):8824.

Lv F, Du Q, Li L, Xi X, Liu Q, Li W, et al. Eriodictyol inhibits glioblastoma migration and invasion by reversing EMT via downregulation of the P38 MAPK/GSK-3β/ZEB1 pathway. European Journal of Pharmacology. 2021;900:174069.

Wang J, Zhu H, Zhang C, Wang H, Yang Z. Baicalein ameliorates cadmium-induced hepatic and renal oxidative damage in rats. Indian Journal of Animal Research. 2019;53(4):523-7.

Singh P, Sharma S, Rath SK. A versatile flavonoid Quercetin: study of its toxicity and differential gene expression in the liver of mice. Phytomedicine Plus. 2022;2(1):100148.

Han MK, Barreto TA, Martinez FJ, Comstock AT, Sajjan US. Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease. BMJ open respiratory research. 2020;7(1):e000392.

Xu K, Ren X, Wang J, Zhang Q, Fu X, Zhang P-C. Clinical development and informatics analysis of natural and semi-synthetic flavonoid drugs: A critical review. Journal of Advanced Research. 2024;63:269-84.

Liu HL, Jiang WB, Xie MX. Flavonoids: recent advances as anti-cancer drugs. Recent patents on anti-cancer drug discovery. 2010;5(2):152-64.

Nath R, Manna S, Panda S, Maity A, Bandyopadhyay K, Das A, et al. Flavonoid Based Development of Synthetic Drugs: Chemistry and Biological Activities. Chemistry & Biodiversity. 2025;22(3):e202401899.

Zha D, Li Y, Luo Y, Liu Y, Lin Z, Lin C, et al. Synthesis and in vitro anti-cancer evaluation of novel flavonoid-based amide derivatives as regulators of the PI3K/AKT signal pathway for TNBC treatment. RSC Medicinal Chemistry. 2022;13(9):1082-99.

Chinnikrishnan P, Aziz Ibrahim IA, Alzahrani AR, Shahzad N, Sivaprakasam P, Pandurangan AK. The role of selective flavonoids on triple-negative breast cancer: an update. Separations. 2023;10(3):207.

Mammen D. Chemical perspective and drawbacks in flavonoid estimation assays. Frontiers in Natural Product Chemistry: Bentham Science Publishers; 2022. p. 189-228.

Safe S, Jayaraman A, Chapkin RS, Howard M, Mohankumar K, Shrestha R. Flavonoids: structure–function and mechanisms of action and opportunities for drug development. Toxicological research. 2021;37(2):147-62.

Hazai L, Zsoldos B, Halmai M, Keglevich P. Flavone hybrids and derivatives as bioactive agents. Applied Sciences. 2024;14(3):1039.

Kumar G, Jain P, Virmani T, Sharma A, Akhtar MS, Aldosari SA, et al. Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin. Therapeutic Delivery. 2024;15(9):717-35.

McKay TB, Emmitte KA, German C, Karamichos D. Quercetin and related analogs as therapeutics to promote tissue repair. Bioengineering. 2023;10(10):1127.

Litvin V, Njoh R. Quercetin as a precursor in the synthesis of analogues of fulvicacids and their antibacterial properties. Voprosy khimii i khimicheskoi tekhnologii. 2021;2:56-64.

Xu T, Wang C, Jiang S, Yang T, Wu X. Glycosylation of luteolin in hydrophilic organic solvents and structure–antioxidant relationships of luteolin glycosides. RSC advances. 2022;12(28):18232-7.

Gu N, Liu S, Qiu C, Zhao L, Pei J. Biosynthesis of 3’-O-methylisoorientin from luteolin by selecting O-methylation/C-glycosylation motif. Enzyme and Microbial Technology. 2021;150:109862.

Li X. Electron Properties of Baicalein and its Derivatives via Quantum Chemistry Calculation: The Effect of Hydroxyl-substitution at A and C Rings. Letters in Organic Chemistry. 2024;21(11):983-91.

Szkudelski T, Konieczna K, Szkudelska K. Regulatory effects of baicalin, a flavonoid compound, on adipocyte metabolism. jOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. 2023;74(4):413-22.

Van Tran C, Tran TTP, Van Tran L, Pham NT, Nguyen LT, Nguyen DT, et al. Synthesis and cytotoxic activity of madecassic acid–silybin conjugate compounds in liver cancer cells. RSC Medicinal Chemistry. 2024;15(10):3418-32.

Vento F, Privitera A, Caruso G, Nicosia A. A Silibinin‐Poly (ε‐Caprolactone) Conjugate as an Enhanced Anti-cancer Agent. Macromolecular Bioscience. 2025;25(4):2400510.

Sastry GN. Screening of phytochemicals for potential breast cancer targets BRCA1 and BARD1: A network pharmacology approach. Indian Journal of Biochemistry and Biophysics (IJBB). 2023;60(5):393-405.

Sharma D, Dhobi M, Lather V, Pandita D. An insight into the therapeutic effects of isoliquiritigenin in breast cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024;397(12):9503-19.

Yuan C-L, Yang X-L, Sun L, Jiang Y-X, Zhang D-D, Huang S. Isoliquiritigenin Suppresses Breast Tumor Development by Enhancing Host Antitumor Immunity. The American Journal of Chinese Medicine. 2024;52(06):1819-41.

Poh-Yen K. Phytochemical Small Molecules as Potential Anti-angiogenesis Targeted Therapy for Triple-Negative Breast Cancer. Revista Brasileira de Farmacognosia. 2024;34(3):451-66.

Peter S, Alven S, Maseko RB, Aderibigbe BA. Doxorubicin-based hybrid compounds as potential anti-cancer agents: a review. Molecules. 2022;27(14):4478.

Staedler D, Idrizi E, Kenzaoui BH, Juillerat-Jeanneret L. Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer chemotherapy and pharmacology. 2011;68(5):1161-72.

Khatoon S, Kalam N, Shaikh MF, Hasnain MS, Hafiz AK, Ansari MT. Nanoencapsulation of polyphenols as drugs and supplements for enhancing therapeutic profile-a review. Current Molecular Pharmacology. 2022;15(1):77-107.

Vieira IRS, Tessaro L, Lima AKO, Velloso IPS, Conte-Junior CA. Recent progress in nanotechnology improving the therapeutic potential of polyphenols for cancer. Nutrients. 2023;15(14):3136.

rights are reserved by Mohd A, Shaikh A. A Systematic Review of Nano-Formulations in Breast Cancer Oncology.

Huang L, Luo S, Tong S, Lv Z, Wu J. The development of nanocarriers for natural products. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2024;16(3):e1967.

Nozhat Z, Heydarzadeh S, Memariani Z, Ahmadi A. Chemoprotective and chemosensitizing effects of apigenin on cancer therapy. Cancer Cell International. 2021;21:1-26.

Sahoo S, Mohapatra P, Sahoo SK. Flavonoids for the treatment of breast cancer, present status and future prospective. Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents). 2023;23(6):658-75.

Crew KD, Ho K, Brown P, Greenlee H, Bevers T, Arun B, et al. Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor‐negative breast cancer. Journal of Human Nutrition and Dietetics. 2015;28(3):272-82.